YD Bio (NASDAQ:YDES) Trading Down 5.6% – Here’s What Happened

YD Bio Limited (NASDAQ:YDES) shares dropped 5.6% during mid-day trading on Tuesday . The company traded as low as $7.33 and last traded at $7.3450. Approximately 9,508 shares changed hands during trading, a decline of 75% from the average daily volume of 37,395 shares. The stock had previously closed at $7.78.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Weiss Ratings restated a “sell (d+)” rating on shares of YD Bio in a research note on Monday, December 29th. Wall Street Zen raised shares of YD Bio from a “sell” rating to a “hold” rating in a research note on Saturday, February 28th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has a consensus rating of “Sell”.

YD Bio Stock Down 10.8%

The stock has a fifty day moving average of $9.97.

Institutional Inflows and Outflows

An institutional investor recently raised its position in YD Bio stock. Geode Capital Management LLC grew its stake in shares of YD Bio Limited (NASDAQ:YDES) by 10.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,363 shares of the biotechnology company’s stock after acquiring an additional 5,292 shares during the period. Geode Capital Management LLC owned about 0.08% of YD Bio worth $711,000 at the end of the most recent quarter.

YD Bio Company Profile

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.